Sudarshan Pharma Approves ₹1,500 Crore Fundraising, Plans US Subsidiary 3 days ago
Sudarshan Pharma Industries Limited's board has approved a fundraising plan of up to ₹1,500 crore. The company also plans to establish a wholly-owned subsidiary, Sudarshan Industries LLC, in the United States. The new subsidiary will focus on manufacturing chemical products, producing pharmaceutical items, and trading in FMCG products. This move aims to expand the company's global presence and diversify its product portfolio.
Sudarshan Pharma Industries Set to Acquire Cibachem Shares for ₹5.5 Crore May 13, 2025
Sudarshan Pharma Industries Reports Robust H2 FY25 Results with 43% Profit Surge May 04, 2025